Hospitalized Older Patients with Infection Refractory to Conventional Antibiotic Therapy Benefit from Fecal Microbiota Transplant.

Background: Options for infection (CDI) refractory to conventional therapy are limited. Fecal microbiota transplant (FMT) is considered safe and effective treatment for recurrent CDI and could be a treatment option for refractory CDI. We investigated the efficacy and safety of FMT in hospitalized patients who were not responding to standard treatments for CDI.